Suche
Mein Konto
Bremen: Police stop father's dangerous sugar rocket project!
In Bremen-Neustadt, a sugar rocket experiment by a father and son failed after the police were alerted.
Bremen: Police stop father's dangerous sugar rocket project!
There was recently an explosive incident in Bremen-Neustadt that put the local police on alert. On August 13, 2025 at 2:30 p.m., a dangerous experiment was discovered that a father (56 years old) was planning with his 11-year-old son. Their project: to build a so-called “sugar rocket”. The idea was to make the boy happy. But the child's mother, concerned about safety, went to the police and informed the authorities about the risky plan.
As the investigation shows, mixed ingredients - sugar and potassium nitrate - were already available in a bag on Lake Werdersee. A team from the Federal Police's defusing group was quickly called in to secure the material and assess its danger. It was taken to a laboratory for analysis while the father is being investigated for a possible violation of the Explosives Act. The police urge caution with such experiments and warn that they are often portrayed as harmless on social networks.
Warnings of dangers
The authorities in Bremen have made it clear that such experiments must be taken seriously. A sugar rocket can quickly become a source of danger if handled incorrectly. “We appeal to all parents to think about the safety of their children and to refrain from such experiments,” explains a police spokesman.
Interestingly, despite such incidents, the use of social media often does not address the invisible dangers. The way they are presented on online platforms sometimes gives the impression that these gimmicks are harmless. This is something to keep in mind next time you research experiments.
The view beyond Bremen
But while such explosive cases dominate the headlines in Bremen, there are also completely different topics of international interest. The company Organon has announced Dermavant Sciences Ltd. to take over. This acquisition is a targeted strategy to expand Organon's dermatology capabilities in the United States. In particular, the product VTAMA®, a non-steroidal treatment for plaque psoriasis in adults, is expected to play a central role. With a purchase price of up to $1.2 billion, this is a huge deal that could also have an impact on health policy.
The connection between these two events - from a local incident affecting safety and parenting to an international health deal - shows how different the challenges and opportunities can be in our world today. Regardless of whether in Bremen or far beyond, this is something to think about and should make us all aware of our responsibility.
Once in focus, stories like these do not go unnoticed, and we will continue to report on what is happening around us. Stay tuned for more information and exciting developments.